What do docking and QSAR tell us about the design of HIV-1 reverse transcriptase nonnucleoside inhibitors?

Despite vigorous studies, effective nonnucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs) are still in demand, not only due to toxicity and detrimental side effects of currently used drugs but also because of the emergence of multidrug-resistant viral strains. In this contribution, we pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Paneth, Agata, Płonka, Wojciech, Paneth, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655543/
https://www.ncbi.nlm.nih.gov/pubmed/29046967
http://dx.doi.org/10.1007/s00894-017-3489-3
Descripción
Sumario:Despite vigorous studies, effective nonnucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs) are still in demand, not only due to toxicity and detrimental side effects of currently used drugs but also because of the emergence of multidrug-resistant viral strains. In this contribution, we present results of docking of 47 inhibitors to 107 allosteric centers of HIV-1 reverse transcriptase. Based on the average binding scores, we have constructed QSAR equations to elucidate directions of further developments in the inhibitor design that come from this structural data. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00894-017-3489-3) contains supplementary material, which is available to authorized users.

Ejemplares similares